LIFEVANTAGE CORP Form SC TO-C: Written communication relating to a tender offer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2013-10-18: Form SC TO-C; Description CREDIT FACILITY; Document form8-ksmhr.htm.
- 2013-09-24: Form SC TO-C; Description SCHEDULE TO-C; Document scheduleto-cprexcommenceme.htm.
- 2013-09-13: Form SC TO-C; Description SC TO-C; Document scto-cscript.htm.
- 2013-09-12: Form SC TO-C; Description SC TO-C; Document scheduleto.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2013-10-18 | SC TO-C | CREDIT FACILITY | form8-ksmhr.htm | |
| 2013-09-24 | SC TO-C | SCHEDULE TO-C | scheduleto-cprexcommenceme.htm | |
| 2013-09-13 | SC TO-C | SC TO-C | scto-cscript.htm | |
| 2013-09-12 | SC TO-C | SC TO-C | scheduleto.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |